Quinoline and quninaldine as naturally occurring inhibitors specific for type A monoamine oxidase
- 1 March 1987
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 40 (11) , 1075-1082
- https://doi.org/10.1016/0024-3205(87)90570-4
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Specific Binding of Glycosylated ?-Galactosidase to Bovine Brain Synaptic MembraneJournal of Neurochemistry, 1986
- The Relative Efficacy of l-Deprenyl, a Selective Monoamine Oxidase Type B Inhibitor, in Endogenous and Nonendogenous DepressionJournal of Clinical Psychopharmacology, 1982
- Parents of High Risk Subjects Defined by Levels of Monoamine Oxidase ActivitySchizophrenia Bulletin, 1980
- FAMILIAL BIOCHEMICAL AND CLINICAL CORRELATES OF ALCOHOLICS WITH LOW PLATELET MONO-AMINE OXIDASE ACTIVITY1979
- Additional evidence for the existence of several forms of mitochondrial monoamine oxidase in the mouseBiochemical Pharmacology, 1968
- Some observations upon a new inhibitor of monoamine oxidase in brain tissueBiochemical Pharmacology, 1968